Literature DB >> 18174855

Time course of juvenile onset recurrent respiratory papillomatosis caused by human papillomavirus.

Michael Hawkes1, Paolo Campisi, Rubeena Zafar, Xerxes Punthakee, Annie Dupuis, Vito Forte, Elizabeth Lee Ford-Jones.   

Abstract

BACKGROUND: With the recent licensure of a new quadrivalent vaccine, many diseases caused by human papillomavirus (HPV) can now be prevented, including recurrent respiratory papillomatosis (RRP). The purpose of this study was to describe the burden and time course of juvenile onset RRP.
METHODS: A retrospective chart review was conducted of children with airway papillomatosis at the Hospital for Sick Children in Toronto, Canada, between 1994 and 2004. Statistical methods included descriptive statistics of the cohort, a repeated events survival model, and nonlinear modeling equations to describe the time course of illness.
RESULTS: Nine hundred twenty-six surgical procedures in 67 patients were identified through a review of surgical records. The median age at diagnosis was 3.2 years (range, 0.1-14.8 years) and the most common presenting symptom was hoarseness (75%). Adjuvant pharmacologic therapy (interferon or cidofovir) was used in 13 cases (19%). HPV types 6 or 11 were identified most commonly as the etiologic agent. Nonlinear modeling equations (exponential and quadratic) fit the observed data well, and were superior to linear models. Repeated events survival analysis identified significant prognostic variables: surgeon, adjuvant therapy, and anatomic score. A decision rule is presented that allows the time to next surgery to be predicted based on the previous surgery and the anatomic score.
CONCLUSIONS: Most patients have a decelerating rate of debulking surgeries over time, well described by our nonlinear modeling equations. Factors affecting the time course of RRP include: inter-surgeon variability, the extent and severity of papillomas at the time of laryngoscopy, and the use of adjuvant medical therapies.

Entities:  

Mesh:

Year:  2008        PMID: 18174855     DOI: 10.1097/INF.0b013e318159833e

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  6 in total

1.  Novel human papilloma virus (HPV) genotypes in children with recurrent respiratory papillomatosis.

Authors:  Ioannis N Mammas; George Sourvinos; Elena Vakonaki; Panagiota Giamarelou; Catherine Michael; Demetrios A Spandidos
Journal:  Eur J Pediatr       Date:  2010-03-07       Impact factor: 3.183

Review 2.  Human papilloma virus (HPV) infection in children and adolescents.

Authors:  Ioannis N Mammas; George Sourvinos; Demetrios A Spandidos
Journal:  Eur J Pediatr       Date:  2008-12-03       Impact factor: 3.183

3.  Effectiveness of cidofovir intralesional treatment in recurrent respiratory papillomatosis.

Authors:  Małgorzata Wierzbicka; Joanna Jackowska; Anna Bartochowska; Agata Józefiak; Witold Szyfter; Witold Kędzia
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-04-26       Impact factor: 2.503

4.  Age at diagnosis, but not HPV type, is strongly associated with clinical course in recurrent respiratory papillomatosis.

Authors:  Farrel J Buchinsky; William L Valentino; Nicole Ruszkay; Evan Powell; Craig S Derkay; Riaz Y Seedat; Virgilijus Uloza; Frederik G Dikkers; David E Tunkel; Sukgi S Choi; Anthony J Mortelliti; Paolo Campisi; Juan C Ospina; Adam J Donne; Robert T Sataloff; Stephen F Conley; John E McClay; Ellen M Friedman; Lisa Elden; Dale A Tylor; Clark A Rosen; Libby J Smith; Graeme J Copley; David E Karas; John M Schweinfurth; Charles M Myer; Brian J Wiatrak; Joseph E Dohar; Steven E Sobol; Robert W Bastian; Richard J H Smith; Marshall E Smith; Abebe M Wassie; James C Post; Garth D Ehrlich
Journal:  PLoS One       Date:  2019-06-13       Impact factor: 3.240

5.  In RRP, serologic response to HPV is frequently absent and slow to develop.

Authors:  Farrel J Buchinsky; Nicole Ruszkay; William Valentino; Craig S Derkay; John E McClay; Robert W Bastian; Charles M Myer; Kevin W Lollar; Dalya Guris
Journal:  PLoS One       Date:  2020-03-11       Impact factor: 3.240

Review 6.  Juvenile-Onset Recurrent Respiratory Papillomatosis Diagnosis and Management - A Developing Country Review.

Authors:  R Y Seedat
Journal:  Pediatric Health Med Ther       Date:  2020-02-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.